Inhibiting HDAC for human hematopoietic stem cell expansion

Journal of Clinical Investigation

Volumn 124, Issue 6, 2014, Pages 2365-2368

  Broxmeyer, Hal E ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1,3 DIOXO 1H,3H BENZO[DE]ISOQUINOLIN 2 YL) N HYDROXYHEXANAMIDE; ALDEHYDE DEHYDROGENASE; ALPHA6 INTEGRIN; CHEMOKINE RECEPTOR CXCR4; FLT3 LIGAND; HISTONE DEACETYLASE; INTERLEUKIN 3; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1; THROMBOPOIETIN; THY 1 ANTIGEN; VALPROIC ACID;

CELL EXPANSION; CELL PROLIFERATION; CELL RENEWAL; CELL SURFACE; CELL SURVIVAL; CHEMOTAXIS; CHROMATIN; ENGRAFTMENT; ENZYME ACTIVITY; ENZYME INHIBITION; EPIGENETICS; ERYTHROID PRECURSOR CELL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; UMBILICAL CORD BLOOD;

ANIMALS; EPIGENESIS, GENETIC; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 84902144207     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI75803     Document Type: Review

References (20)

1. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013;122(4):491-498.
2. Flores-Guzman P, Fernandez-Sanchez V, Mayani H. Concise review: ex vivo expansion of cord bloodderived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine. Stem Cells Transl Med. 2013;2(11):830-838.
3. Felsenfeld G. A brief history of epigenetics. Cold Spring Harb Perspect Biol. 2014;6(1):a018200.
4. Chaurasia P, Gajzer DC, Schaniel C, D'Souza S, Hoffman R. Epigenetic reprogramming induces the expansion of cord blood stem cells. J Clin Invest. 2014;124(6):2378-2395.
5. Chaurasia P, Berenzon D, Hoffman R. Chromatinmodifying agents promote the ex vivo production of functional human erythroid progenitor cells. Blood. 2011;117(17):4632-4641.
6. Shaheen M, Broxmeyer HE. Hematopoietic cytokines and growth factors. In: Broxmeyer HE, eds. Cord Blood Biology, Transplantation, Banking, and Regulation. Bethesda, Maryland, USA: AABB Press; 2011:35-74.
7. Shaheen M, Broxmeyer HE. Principles of cytokine signaling. In: Hoffman R, Benz EJ Jr, Silberstein LE, Heslop H, Weitz JI, Anastasi J, eds. Hematology: Basic Principles and Practice. 6th ed. Philadelphia, Pennsylania, USA: Elsevier Saunders; 2013:136-146.
8. Broxmeyer HE, et al. Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis. Nat Med. 2012;18(12):1786-1796.
9. Ou X, O'Leary HA, Broxmeyer HE. Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types. Blood. 2013;122(2):161-169.
10. Christopherson KW 2nd, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science. 2004;305(5686):1000-1003.
11. Csaszar E, et al. Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling. Cell Stem Cell. 2012;10(2):218-229.
12. Guo Y, Mantel C, Hromas RA, Broxmeyer HE. Oct. 4 is critical for survival/antiapoptosis of murine embryonic stem cells subjected to stress, effects associated with Stat3/Survivin. Stem Cells. 2008;26(1):30-34.
13. Sack MN, Finkel T. Mitochondrial metabolism, sirtuins, and aging. Cold Spring Harb Perspect Biol. 2012;4(12):a013102.
14. Han M-K, Song EK, Guo Y, Ou X, Mantel C, Broxmeyer HE. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell. 2008;2(3):241-251.
15. Zhang ZN, Chung SK, Xu Z, Xu Y. Oct4 maintains the pluripotency of human embryonic stem cells by inactivating p53 through Sirt1-mediated deacetylation. Stem Cells. 2014;32(1):157-165.
16. Ou X, Lee MR, Huang X, Messina-Graham S, Broxmeyer HE. SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells. 2014;32(5):1183-1194.
17. Ou X, et al. SIRT1 deficiency compromises mouse embryonic stem cell hematopoietic differentiation, and embryonic and adult hematopoiesis in the mouse. Blood. 2011;117(2):440-450.
18. Broxmeyer HE, et al. A role for DEK in stem/progenitor cell biology. Stem Cells. 2013;31(8):1447-1453.
19. Li W, Li K, Wei W, Ding S. Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell. 2013;13(3):270-283.
20. Lee MR, et al. Epigenetic regulation of Nanog by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming. Stem Cells. 2013;31(4):666-681.